v3.26.1
COMMITMENTS AND CONTINGENCIES (Details Narrative)
 1 Months Ended 3 Months Ended 12 Months Ended
Dec. 20, 2023
USD ($)
Integer
Aug. 01, 2023
USD ($)
shares
Aug. 31, 2025
USD ($)
Aug. 31, 2024
USD ($)
Oct. 31, 2019
USD ($)
Jul. 31, 2019
USD ($)
Mar. 31, 2026
USD ($)
Mar. 30, 2026
Mar. 31, 2025
USD ($)
Dec. 31, 2025
USD ($)
Loss Contingencies [Line Items]                    
Intangible assets, net             $ 17,860,273     $ 18,640,673
BIAKOS License Agreement [Member]                    
Loss Contingencies [Line Items]                    
Payment for additional royalties             58,881   $ 37,500  
BIAKOS License Agreement [Member] | Rochal Industries LLC [Member] | Minimum [Member]                    
Loss Contingencies [Line Items]                    
Royalty percentage           2.00%        
BIAKOS License Agreement [Member] | Rochal Industries LLC [Member] | Maximum [Member]                    
Loss Contingencies [Line Items]                    
Royalty percentage           4.00%        
Royalties paid                   150,000
BIAKOS Agreement [Member] | Maximum [Member]                    
Loss Contingencies [Line Items]                    
Payment for additional royalties           $ 1,000,000        
ABF License Agreement [Member]                    
Loss Contingencies [Line Items]                    
Increase in royalty annual percentage         10.00%          
Sales of royalties recognized             0      
ABF License Agreement [Member] | Minimum [Member]                    
Loss Contingencies [Line Items]                    
Royalty percentage         2.00%          
Payment for additional royalties         $ 50,000          
ABF License Agreement [Member] | Maximum [Member]                    
Loss Contingencies [Line Items]                    
Royalty percentage         4.00%          
Payment for additional royalties         $ 75,000          
ABF License Agreement [Member] | Maximum [Member] | Product and Service, Other [Member]                    
Loss Contingencies [Line Items]                    
Payment for additional royalties         $ 500,000          
Debrider License Agreement [Member]                    
Loss Contingencies [Line Items]                    
Sales of royalties recognized             0      
Impairment charge                   1,200,000
Intangible assets, net                   $ 0
BMI License Agreement [Member]                    
Loss Contingencies [Line Items]                    
Royalties paid             $ 0      
License Agreement Commitments Description             the Company was appointed by BMI as the exclusive distributor to promote, market, offer to sell, transfer, distribute and sell the Products for trauma indications inside the United States and its territories for an initial five-year term, which term may be automatically renewed for successive two-year periods at the Company’s discretion      
Royalties percentage               3.00%    
Royalty payments year one             $ 100,000      
Royalty payments year two             200,000      
Royalty payments year three             300,000      
Applied Asset Purchase Agreement [Member]                    
Loss Contingencies [Line Items]                    
Assets purchase price   $ 15,250,000                
Installment payable   2,500,000                
Payment of installment     $ 625,000 $ 625,000            
Earnout payable             0      
Applied Asset Purchase Agreement [Member] | Cash Closing Consideration [Member]                    
Loss Contingencies [Line Items]                    
Cash consideration paid   $ 9,750,000                
Applied Asset Purchase Agreement [Member] | Stock Closing Consideration [Member]                    
Loss Contingencies [Line Items]                    
Shares issued as consideration | shares   73,809                
Value of shares issued as consideration   $ 3,000,000.0                
Applied Asset Purchase Agreement [Member] | Maximum [Member]                    
Loss Contingencies [Line Items]                    
Earnout payable   $ 10,000,000.0                
Services Agreement [Member]                    
Loss Contingencies [Line Items]                    
Purchase agreement description   As consideration for the Petito Services, the Owner was entitled to receive: (i) a base salary of $12,000 per month during the term of the Petito Services Agreement, (ii) a royalty payment equal to 3% of the actual collections from net sales of certain products the Owner develops or codevelops that reach commercialization, (iii) a royalty payment equal to 5% for the first $50.0 million in aggregate collections from net sales of certain future products and a royalty payment of 2.5% on aggregate collections from net sales of certain future products on any amounts exceeding $50.0 million but up to $100.0 million, (iv) $500,000 in cash in the event that 510(k) clearance is issued for any future product accepted by the Company and (v) $1.0 million in cash in the event that a U.S. patent is issued for a certain product; provided that with respect to the incentive payments described in (iv) and (v) of the foregoing, the Owner shall not earn more than $2.5 million.                
License Agreement [Member]                    
Loss Contingencies [Line Items]                    
Number of unique collagen peptides | Integer 18                  
Outstanding units percentage 10.00%                  
License Agreement [Member] | Minimum [Member]                    
Loss Contingencies [Line Items]                    
Royalties paid             $ 0      
Payment for additional royalties $ 50,000                  
Royalty expense percentage 1.50%                  
License Agreement [Member] | Minimum [Member] | Royalty Agreement Terms [Member]                    
Loss Contingencies [Line Items]                    
Payment for additional royalties $ 100,000                  
License Agreement [Member] | Maximum [Member]                    
Loss Contingencies [Line Items]                    
Royalty expense percentage 3.00%